Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
Grynblat J, Khouri C, Hlavaty A, Jais X, Savale L, Chaumais MC, Kularatne M, Jevnikar M, Boucly A, Antigny F, Perros F, Simonneau G, Sitbon O, Humbert M, Montani D; French PH Network PULMOTENSION investigators.
Grynblat J, et al. Among authors: kularatne m.
Eur Respir J. 2024 May 2:2302158. doi: 10.1183/13993003.02158-2023. Online ahead of print.
Eur Respir J. 2024.
PMID: 38697649